Search

Your search keyword '"Pukitis, Aldis"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Pukitis, Aldis" Remove constraint Author: "Pukitis, Aldis"
111 results on '"Pukitis, Aldis"'

Search Results

1. THU-092 Enrolling patients in ACLF trials-the need to increase ACLF awareness (DHELIVER trial)

2. Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study

3. Exocrine pancreas insufficiency in chronic pancreatitis – Risk factors and associations with complications. A multicentre study of 1869 patients

4. Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis

6. Patient reported exposure to smoking and alcohol abuse are associated with pain and other complications in patients with chronic pancreatitis

7. Pancreatitis - Microbiome As Predictor of Severity (P-MAPS): a prospective international multicentre translational study

8. Pancreatic calcifications associate with diverse aetiological risk factors in patients with chronic pancreatitis: A multicentre study of 1500 cases

9. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis

11. Neuroendocrine Carcinoma of the Extrahepatic Bile Ducts: A Case Report

12. Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis

14. Inflammatory bowel disease does not alter the clinical features and the management of acute pancreatitis: A prospective, multicentre, exact-matched cohort analysis

15. Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study

16. Mo1814 PREVALENCE, ETIOLOGY AND OUTCOME OF ACUTE PANCREATITIS IN INFLAMMATORY BOWEL DISEASE: EUROPEAN PANDORA STUDY

17. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

18. Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease

19. sj-pdf-1-ueg-10.1177_2050640620901973 - Supplemental material for Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases

20. 948 A NOVEL SUBCUTANEOUS INFLIXIMAB (CT-P13) IN PATIENTS WITH ACTIVE CROHN'S DISEASE AND ULCERATIVE COLITIS: WEEK54 AND SWITCHING RESULTS FROM A MULTICENTER, RANDOMISED CONTROLLED PIVOTAL TRIAL

21. Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases

22. Tu1877 EVALUATION OF CLINICAL RELATIONSHIP BETWEEN FECAL CALPROTECTIN AND ENDOSCOPIC RESULT IN ULCERATIVE COLITIS PATIENTS TREATED WITH INFILXIMAB SUBCUTANEOUS AND INTRAVENOUS THERAPY: RESULTS FROM A MULTICENTER, RANDOMIZED, CONTROLLED PIVOTAL TRIAL

24. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

25. European evidence-based guidelines on pancreatic cystic neoplasms

26. European evidence-based guidelines on pancreatic cystic neoplasms

29. The use of Early Achievable SeveritY (EASY) index is beneficial for rapid risk stratification in acute pancreatitis on hospital admission

30. Tu1715 – A Novel Formulation of Ct-P13 (Infliximab Biosimilar) for Subcutaneous Administration: 1-Year Result from a Phase I Open-Label Randomized Controlled Trial in Patients with Active Crohn's Disease

31. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis

32. Association of multiple patient and disease characteristics with the presence and type of pain in chronic pancreatitis.

33. Early achievable SeveritY (EASY) index for simple and accurate expedite risk stratification in acute pancreatitis

34. Tu2018 - Novel Formulation of CT-P13 (Infliximab Biosimilar) for Subcutaneous Administration: Initial Results from a Phase I Open-Label Randomized Controlled Trial in Patients with Active Crohn's Disease

38. Early Achievable SeveritY (EASY) index for simple and accurate expedite risk stratification in acute pancreatitis

42. The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohort.

48. Effect of Infliximab Induction Therapy on Secondary Systemic Amyloidosis Associated with Crohn's Disease: Case Report and Review of the Literature.

49. European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations

50. A Young Female with a Hepatic Epithelioid Hemangioendothelioma.

Catalog

Books, media, physical & digital resources